Corrigendum to "Suppression of lipopolysaccharide-stimulated inducible nitric oxide synthase (iNOS) expression by a novel humulene derivative in macrophage cells" [International Immunopharmacology 9 (2009)844-849] (DOI:10.1016/j.intimp.2009.03.005);Suppression of lipopolysaccharide-stimulated inducible nitric oxide synthase (iNOS) expression by a novel humulene derivative in macrophage cells

International Immunopharmacology

Volumn 9, Issue 7-8, 2009, Pages 844-849

  Min, Hye Young ^a   Kim, Moon Sun ^a   Jang, Dae Sik ^a,b   Park, Eun Jung ^a   Seo, Eun Kyoung ^a   Lee, Sang Kook ^a  

^a Ewha Womans University   (South Korea)

^b Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

5 hydroxyzerumbone; Heme oxygenase 1 (HO 1); Inducible nitric oxide synthase (iNOS); NF B; Nitric oxide (NO)

Indexed keywords

5 HYDROXYZERUMBONE; GINGER EXTRACT; HEME OXYGENASE 1; HUMULENE DERIVATIVE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TOXICITY TESTING; TRANSCRIPTION INITIATION; UPREGULATION;

EID: 67349280833     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.03.024     Document Type: Erratum

References (28)

1. Nathan C., and Xie Q.W. Regulation of biosynthesis of nitric oxide. J Biol Chem 269 (1994) 13,725-13,728
2. Kröncke K.D., Fensel K., and Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 113 (1998) 147-156
3. Coleman J.W. Nitric oxide in immunity and inflammation. Int Immunopharmacol 1 (2001) 1397-1406
4. Bhuiyan M.N.I., Chowdhury J.U., and Begum J. Chemical investigation of the leaf and rhizome essential oils of Zingiber zerumbet (L.) Smith from Bangladesh. Bangladesh J Pharmacol 4 (2009) 9-12
5. Somchit M.N., and Shukriyah M.H.N. Anti-inflammatory property of ethanol and water extracts of Zingiber zerumbet. Indian J Pharmacol 35 (2003) 181-182
6. Jang D.S., Han A.R., Park G., Jhon G.J., and Seo E.K. Flavonoids and aromatic compounds from the rhizomes of Zingiber zerumbet. Arch Pharm Res 27 (2004) 386-389
7. Jang D.S., and Seo E.K. Potentially bioactive two new natural sesquiterpenoids from the rhizomes of Zingiber zerumbet. Arch Pharm Res 28 (2005) 294-296
8. Chien T.Y., Chen L.G., Lee C.J., Lee F.Y., and Wang C.C. Anti-inflammatory constituents of Zingiber zerumbet. Food Chem 110 (2008) 584-589
9. Murakami A., Shigemori T., and Ohigashi H. Zingiberaceous and Citrus constituents, 1′-acetoxychavicol acetate, zerumbone, auraptene, and nobiletin, suppress lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 murine macrophages through different modes of action. J Nutr 135 (2005) 2987S-2992S
10. Murakami A., Takahashi D., Kinoshita T., Koshimizu K., Kim H.W., Yoshihiro A., et al. Zerumbone, a Southeast Asian ginger sesquiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: the α, β-unsaturated carbonyl group is a prerequisite. Carcinogenesis 23 (2002) 795-802
11. Sung B., Jhurani S., Ahn K.S., Mastuo Y., Yi T., Guha S., et al. Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells. Cancer Res 68 (2008) 8938-8944
12. Jang D.S., Min H.Y., Kim M.S., Han A.R., Windono T., Jeohn G.H., et al. Humulene derivatives from Zingiber zerumbet with the inhibitory effects on lipopolysaccharide-induced nitric oxide production. Chem Pharm Bull 53 (2005) 829-831
13. Bae I.K., Min H.Y., Han A.R., Seo E.K., and Lee S.K. Suppression of lipopolysaccharide-induced expression of inducible nitric oxide synthase by brazilin in RAW 264.7 macrophage cells. Eur J Pharmacol 513 (2005) 237-242
14. Moon K.Y., Hahn B.S., Lee J., and Kim Y.S. A cell-based assay system for monitoring NF-κB activity in human HaCaT transfectant cells. Anal Biochem 292 (2001) 17-21
15. Hobbs A.J., Higgs A., and Moncada S. Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol 39 (1999) 191-220
16. Vane J.R., Bakhle Y.S., and Botting R.M. Cyclooxygenase 1 and 2. Annu Rev Pharmacol Toxicol 38 (1998) 97-120
17. Wagener F.A.D.T.G., Volk H.D., Willis D., Abraham N.G., Soares M.P., Adema G.J., et al. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 55 (2003) 551-571
18. 2 and 2-Cyclopenten-1-one: role of the heat shock response. Mol Pharmacol 64 (2003) 85-93
19. Bachelier A., Mayer R., and Klein C.D. Sesquiterpene lactones are potent and irreversible inhibitors of the antibacterial target enzyme MurA. Bioorg Med Chem Lett 16 (2006) 5605-5609
20. Medeiros R., Passos G.F., Vitor C.E., Koepp J., Mazzuco T.L., Pianowski L.F., et al. Effect of two active compounds obtained from the essential oil of Cordia verbenacea on the acute inflammatory responses elicited by LPS in the rat paw. Br J Pharmacol 151 (2007) 618-627
21. Fernandes E.S., Passos G.F., Medeiros R., da Cunha F.M., Ferreira J., Campos M.M., et al. Anti-inflammatory effects of compounds alpha-humulene and (-)-trans-caryophyllene isolated from the essential oil of Cordia verbenacea. Eur J Pharmacol 569 (2007) 228-236
22. Lee J.M., Li J., Johnson D.A., Stein T.D., Kraft A.D., Calkins M.J., et al. Nrf2, a multi-organ protector?. FASEB J 19 (2005) 1061-1066
23. Nakamura Y., Yoshida C., Murakami A., Ohigashi H., Osawa T., and Uchida K. Zerumbone, a tropical ginger sesquiterpene, activates phase II drug metabolizing enzymes. FEBS Lett 572 (2004) 245-250
24. Kondo M., Oya-Ito T., Kumagai T., Osawa T., and Uchida K. Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress. J Biol Chem 276 (2001) 12,076-12,083
25. Colville-Nash P.R., Qureshi S.S., Willis D., and Willoughby D.A. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase-1. J Immunol 161 (1998) 978-984
26. Guha M., and Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13 (2001) 85-94
27. García-Piñeres A.J., Castro V., Mora G., Schmidt T.J., Strunck E., Pahl H.L., et al. Cysteine 38 in p65/NF-κB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J Biol Chem 276 (2001) 39,713-39,720
28. Sandur S.K., Ichikawa H., Pandey M.K., Kunnumakkara A.B., Sung B., Sethi G., et al. Role of pro-oxidants antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med 43 (2007) 568-580